PFI and independent sector care again under UK political spotlight
This article was originally published in Clinica
Executive Summary
The UK health system's increasing reliance on the independent sector has been defended by right-wing think-tank Civitas from criticism by the British Medical Association (BMA). But the jury is still out, Clinica suggests, as to how far certain policies – such as the Private Finance Initiative (PFI) and Independent Sector Treatment Centres (ISTCs) – should be intensified or reviewed, and the argument holds the key to future medtech spending.
You may also be interested in...
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.